Urinary excretion of urodilatin in patients with cirrhosis

Hepatology

Volumn 24, Issue 6, 1996, Pages 1428-1432

  Saló, Joan ^a   Jiménez, Wladimiro ^a   Kuhn, Micaela ^b   Ginès, Angels ^a   Ginès, Pere ^a   Fernández Esparrach, Glòria ^a   Angeli, Paolo ^a   Clària, Joan ^a   Bataller, Ramón ^a   Arroyo, Vicente ^a   Forssmann, Wolf Georg ^b   Rod́es, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Niedersachsisches Inst P   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; SODIUM ION; URODILATIN;

ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; SODIUM RETENTION; URINARY EXCRETION;

EID: 16144361961     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008938175     Document Type: Article

References (42)

1. Lewicki JA, Protter AA. Physiological studies of the natriuretic peptide family. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven, 1995:1029-1053.
2. Maack T. Receptors of natriuretic peptides: structure, function and regulation. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven, 1995:1001-1019.
3. Suga S, Nakao K, Hosoda K, Mukiyama M, Ogawa Y, Shirakami G, Arai H, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992;130:229-239.
4. Gerbes AL, Arendt RM, Paumgartner G. Atrial natriuretic factor: possible implications in liver disease. J Hepatol 1987;5:123-132.
5. Ginès P, Jiménez W, Arroyo V, Navasa M, López C, Titó LI, Serra A, et al. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splachnic extraction. HEPATOLOGY 1988;8:636-642.
6. Morgan TR, Imada T, Hollister AS, Inagami T. Plasma human atrial natriuretic factor in cirrhosis and ascites with and without functional renal failure. Gastroenterology 1988;95:1641-1647.
7. Epstein M. Atrial natriuretic factor in patients with liver disease. Am J Nephrol 1989;9:89-100.
8. Gerbes AL, Wernze H, Arendt RM, Riedel A, Janerbruch T, Paumgartner G. Atrial natriuretic factor and renin-aldosterone in volume regulation in patients with cirrhosis. HEPATOLOGY 1989;9:417-422.
9. Salerno F, Badalamenti S, Moser P, Lorenzano E, Incerti P, Dioguardi N. Atrial natriuretic factor in cirrhotic patients with tense ascites: effect of large-volume paracentesis. Gastroenterology 1990;98:1063-1070.
10. Jiménez W, Gutkowska J, Ginès P, Arroyo V, Rivera F, Rodés J. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites. HEPATOLOGY 1991;14:601-607.
11. Angeli P, Caregaro L, Menon F, Sacerdoti D, De Toni R, Merkel C, Gatta A. Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: pathophysiological and clinical implications. HEPATOLOGY 1992;16:1389-1394.
12. Warner L, Skorecki K, Blendis LM, Epstein M. Atrial natriuretic factor in liver disease. HEPATOLOGY 1993;17:500-513.
13. Gerbes AL. The role of atrial natriuretic peptide (ANP) in chronic liver disease. Pharmacol Ther 1993;58:381-390.
14. Angeli P, Jiménez W, Arroyo V, Mackenzie HS, Zhong PL, Clària J, Rivera F, et al. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites. HEPATOLOGY 1994;20:948-954.
15. Bernardi M, Fornalè L, Di Marco C, Trevisani F, Baraldini M, Gasbarrinin A, De Collibus C, et al. Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. J Hepatol 1995;22:309-318.
16. La Villa G, Romanelli RG, Casini VR, Tosti-Guerra C, De Feo ML, Marra F, Laffi G, et al. Plasma levels of brain natriuretic peptide in patients with cirrhosis. HEPATOLOGY 1992;16:156-161.
17. Warner LC. The role of resistance to atrial natriuretic peptide and the pathogenesis of sodium retention and hepatic cirrhosis. In: Brenner BM, Laragh J, eds. Progress in atrial peptide research. Vol 3. New York: Raven, 1989:185-203.
18. Goetz KL. Renal natriuretic peptide (urodilatin?) and atriopeptin: evolving concepts. Am J Physiol 1991;261:F921-F932.
19. Gunning M, Brenner BM. Urodilatin. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis, and management. New York: Raven, 1995:1021-1027.
20. Drummer C, Fiedler F, Bub A, Kleefeld D, Dimitriades E, Gerzer R, Forssmann WG. Development and application of a urodilatin (CDD/ANP-95-126)-specific radioimmunoassay. Pflüggers Arch 1993;423:372-377.
21. Asbert M, Jiménez W, Gaya J, Ginès P, Arroyo V, Rivera F, Rodés J. Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. J Hepatol 1992;15:179-183.
22. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977;21: 625-636.
23. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg AH. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
24. Totsune K, Takahashi K, Murakami O, Satoh F, Sone M, Saito T, Sasano H, et al. Natriuretic peptides in the human kidney. Hypertension 1994; 24:758-762.
25. Schultz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG. Isolation and structural analysis of "urodilatin", a new peptide of the cardiolatin-(ANP)-family, extracted from human urine. Klin Wochenschr 1988;66:752-759.
26. Feller SM, Gagelmann M, Forssmann WG. Urodilatin: a newly described member of the ANP family. Trends Pharmacol Sci 1989;10:93-94.
27. Ritter D, Chao J, Needleman P, Tetens E, Greenwald JE. Localization, synthetic regulation and biology of renal atriopeptin-like prohormone. Am J Physiol 1992;263:F503-509.
28. Schultz-Knappe P, Honrath U, Forssmann WG, Sonnenberg H. Endogenous natriuretic peptides: effect on collecting duct function in rat kidney. Am J Physiol 1990;259:F415-F418.
29. Valentin JP, Sechi LA, Qiu C, Schambelan M, Humphreys MH. Urodilatin binds to and activates renal receptors for atrial natriuretic peptide. Hypertension 1993;21:432-438.
30. Saxenhofer H, Fitzgibbon WR, Paul RV. Urodilatin: binding properties and stimulation of cGMP generation in rat kidney cells. Am J Physiol 1993;264:F267-F273.
31. Koike J, Nonoguchi H, Terada Y, Tomita K, Marumo F. Effect of urodilatin on cGMP accumulation in the kidney. J Am Soc Nephrol 1993;3:1705-1709.
32. Saxenhofer H, Rasell A, Weidmann P, Forssmann WG, Bub A, Ferrari P, Shaw SG. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol 1990;259:F832-F838.
33. Hildebrant DA, Mizelle HL, Brands MW, Hall JE. Comparison of renal actions of urodilatin and atrial natriuretic peptide. Am J Physiol 1992; 262:R395-R399.
34. Kentsch M, Ludwig D, Drummer C, Gerzer R, Müller-Esch. Haemodynamic and renal effects of urodilatin in healthy volunteers. Eur J Clin Invest 1992;22:319-325.
35. Bestle MH, Bie P. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs. Acta Physiol Scand 1993;149:77-83.
36. Gagelmann MD, Hock D, Forssmann WG. Urodilatin (CDD-ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (α-hANP/cdd-99-126). FEBS Lett 1988;233:249-254.
37. Abassi ZA, Tate J, Hunsberger S, Klein H, Trachewsky D, Keiser HR. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Am J Physiol 1992;263:E870-E876.
38. Goetz K, Drummer C, Zhu JL, Leadley R, Fiedler F, Gerzer R. Evidence that urodilatin, rather than ANP, regulates renal sodium excretion. J Am Soc Nephrol 1990;1:867-874.
39. Drummer C, Gerzer R, Heer M, Molz B, Bie P, Schlossberger M, Stadaeger C, et al. Effects of an acute saline infusion on fluid and electrolyte metabolism in humans. Am J Physiol 1992;262:F744-F754.
40. Heer M, Drummer C, Baisch F, Gerzer R. Long-term elevations of dietary sodium produce parallel increases in the renal excretion of urodilatin and sodium. Pflüggers Arch 1993;425:390-394.
41. Drummer C, Fiedler F, König A, Gerzer R. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man. J Am Soc Nephrol 1991;1:1109-1113.
42. 99-126 (ANF) in patients with cirrhosis. Am J Gastroenterol 1990;85:1155-1159.